These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4073791)

  • 21. Serum total hydroxyproline assay: effects of age, sex and Paget's bone disease.
    Gilbertson TJ; Brunden MN; Gruszczyk SB; Whyte MP; Burnett MA
    J Clin Chem Clin Biochem; 1983 Mar; 21(3):129-32. PubMed ID: 6854222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences in the treatment of Paget's disease of bone with mithramycin.
    Ryan WG; Schwartz TB; Northrop G
    JAMA; 1970 Aug; 213(7):1153-7. PubMed ID: 5468261
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC; Meunier P; Terrier M; David L; Vignon G
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal vitamin D metabolism in Paget's disease of bone.
    Guillard-Cumming DF; Beard DJ; Douglas DL; Johnson SK; Lawson-Matthew PJ; Russell RG; Kanis JA
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):559-66. PubMed ID: 3872746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum osteocalcin concentrations in Paget's disease of bone.
    Wilkinson MR; Wagstaffe C; Delbridge L; Wiseman J; Posen S
    Arch Intern Med; 1986 Feb; 146(2):268-71. PubMed ID: 3484940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mithramycin in Paget's disease.
    Epstein S
    S Afr Med J; 1974 Jun; 48(31):1328-30. PubMed ID: 4276946
    [No Abstract]   [Full Text] [Related]  

  • 29. Mithramycin therapy in Paget's disease.
    Russell AS; Lentle BC
    Can Med Assoc J; 1974 Feb; 110(4):397-400. PubMed ID: 4273095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newer agents in treating Paget's disease of bone.
    Goldfield EB
    Geriatrics; 1974 Dec; 29(12):61-9. PubMed ID: 4279196
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.
    Papapoulos SE; Frolich M; Mudde AH; Harinck HI; vd Berg H; Bijvoet OL
    J Clin Endocrinol Metab; 1987 Jul; 65(1):89-94. PubMed ID: 3495547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminohexane diphosphonate in the treatment of Paget's disease of bone.
    Atkins RM; Yates AJ; Gray RE; Urwin GH; Hamdy NA; Beneton MN; Rosini S; Kanis JA
    J Bone Miner Res; 1987 Aug; 2(4):273-9. PubMed ID: 3455614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin-1 and Paget's bone disease: is there a link?
    Tarquini R; Perfetto F; Tarquini B
    Calcif Tissue Int; 1998 Aug; 63(2):118-20. PubMed ID: 9685515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of biochemical markers of bone turnover in Paget's disease of bone].
    Vignot E; Meunier PJ
    Ann Biol Clin (Paris); 2001; 59(3):309-11. PubMed ID: 11397680
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
    N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of clinical and humoral data in 148 patients with Piaget's bone disease].
    Fromm GA; Roca JF; Mautalén CA; Casco C
    Medicina (B Aires); 1980; 40(6 Pt 1):635-42. PubMed ID: 22167694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of gallium to treat Paget's disease of bone: a pilot study.
    Matkovic V; Apseloff G; Shepard DR; Gerber N
    Lancet; 1990 Jan; 335(8681):72-5. PubMed ID: 1967419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of Paget's disease with salmon calcitonin].
    Manderlier T; Fuss M; Brauman J; Orloff S; Bergans A; Corvilain J
    Rev Rhum Mal Osteoartic; 1977 Jan; 44(1):59-66. PubMed ID: 319520
    [No Abstract]   [Full Text] [Related]  

  • 39. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE; Frölich M
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between serum osteocalcin and 24,25-dihydroxyvitamin D levels in Paget's disease of bone.
    Castro-Errecaborde N; de la Piedra C; Rapado A; Alvarez-Arroyo MV; Torres R; Traba ML
    J Clin Endocrinol Metab; 1991 Feb; 72(2):462-6. PubMed ID: 1991815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.